{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:25:06Z","timestamp":1793942706082,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.09.113","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:46:36Z","timestamp":1791848796000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1064-2257","authenticated-orcid":false,"given":"Angela D.","family":"Mazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib1","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.113_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.eprac.2026.09.113_bib4","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eprac.2026.09.113_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.113_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-analysis","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.eprac.2026.09.113_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.113_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/dc18-1738","article-title":"The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome","volume":"42","author":"Kakoly","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.113_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when aging","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.113_bib11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","article-title":"The phenotype of polycystic ovary syndrome ameliorates with aging","volume":"96","author":"Brown","year":"2011","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.113_bib12","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/diagnostics12102313","article-title":"Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the Rotterdam phenotype in influencing the metabolic status","volume":"12","author":"Carmina","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.113_bib13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.113_bib14","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/den482","article-title":"Long-term follow-up of women with PCOS: reproductive outcome and ovarian morphology","volume":"24","author":"Hudecova","year":"2009","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.113_bib15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/humrep\/deu182","article-title":"Anti-m\u00fcllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study","volume":"29","author":"Pinola","year":"2014","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.eprac.2026.09.113_bib16","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.thromres.2015.10.022","article-title":"Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome","volume":"136","author":"Okoroh","year":"2015","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.113_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with PCOS","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.113_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/humrep\/dew329","article-title":"Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus-a prospective, population-based cohort study","volume":"32","author":"Ollila","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eprac.2026.09.113_bib21","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/EJE-16-0373","article-title":"Management of endocrine disease: morbidity in polycystic ovary syndrome","volume":"176","author":"Glintborg","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/cen.12830","article-title":"The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach","volume":"83","author":"Ranasinha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.eprac.2026.09.113_bib23","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib24","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.113_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with PCOS have intrinsic insulin resistance in euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"25","key":"10.1016\/j.eprac.2026.09.113_bib26","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.113_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.113_bib29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with PCOS: cardiovascular risk and hormonal characteristics","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15171\/jcvtr.2018.10","article-title":"Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"10","author":"Hallajzadeh","year":"2018","journal-title":"J Cardiovasc Thorac Res"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.113_bib33","article-title":"Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"Meda","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.113_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/biomedicines13040855","article-title":"MASLD: prevalence, mechanisms, and sex-based therapies in postmenopausal women","volume":"13","author":"Milani","year":"2025","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.eprac.2026.09.113_bib35","doi-asserted-by":"crossref","first-page":"R238","DOI":"10.1530\/EC-18-0129","article-title":"Cardiometabolic risk in polycystic ovary syndrome","volume":"7","author":"Bajuk Studen","year":"2018","journal-title":"Endocr Connect"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.113_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.eprac.2026.09.113_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1676534","article-title":"Silent inflammation: a hidden cause of liver fibrosis","volume":"17","author":"Sch\u00f6n","year":"2026","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.113_bib39","first-page":"1037","article-title":"Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis","volume":"8","author":"Turola","year":"2015","journal-title":"Dis Model Mech"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.113_bib40","doi-asserted-by":"crossref","first-page":"sfaf260","DOI":"10.1093\/ckj\/sfaf260","article-title":"The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management","volume":"18","author":"Moncho","year":"2025","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/cancers15020485","article-title":"Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management","volume":"15","author":"Pati","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.eprac.2026.09.113_bib42","doi-asserted-by":"crossref","first-page":"1674477","DOI":"10.3389\/fendo.2025.1674477","article-title":"Mitochondrial bioenergetics dysfunction in T2DM: linking oxidative stress to insulin resistance","volume":"16","author":"Feng","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2026.09.113_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.20517\/mtod.2024.42","article-title":"Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease","volume":"4","author":"Lonardo","year":"2024","journal-title":"Metab Target Organ Damage"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.113_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in PCOS: a systematic review and meta-analysis","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.113_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","article-title":"The menopause transition: signs, symptoms, and management options","volume":"106","author":"Santoro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.113_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ogc.2011.05.006","article-title":"Vasomotor symptoms and menopause: findings from the SWAN study","volume":"38","author":"Thurston","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.113_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.09.113_bib53","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.09.113_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1472-6823-13-47","article-title":"Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study","volume":"13","author":"Gayoso-Diz","year":"2013","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib55","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.eprac.2026.09.113_bib56","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.113_bib57","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.113_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.113_bib48","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1111\/dom.16549","article-title":"Tirzepatide and cardiometabolic parameters in obesity: summary of current evidence","volume":"27","author":"Sattar","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.09.113_bib49","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.113_bib50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.113_bib51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:39:44Z","timestamp":1793939984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26012607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S1530891X26012607"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.113","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}